CORC

在结果中检索

CORC

浏览/检索结果: 共38条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Efficacy evaluation of maritime AtoN by fuzzy AHP approach 会议论文
作者:  Nie, Ziyi;  Jiang, Zhonglian;  Chu, Xiumin;  Yu, Zhen
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Safety and efficacy of repeated intra-hepatic artery and intravenous infusion of ET140202, a novel anti-AFP/MHC complex T-cell, in advanced hepatocellular carcinoma. 会议论文
作者:  Peng, Min;  Li, Na;  Chang, Chelsea;  Yao, Yi;  Xu, Bin
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Efficacy and safety of shorter duration of adjuvant trastuzumab for patients with HER2 positive early breast cancer: A meta-analysis of randomized controlled trials 会议论文
作者:  Li, J.;  Wang, G.;  Wu, Q.;  Chen, C.;  Tu, Y.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Safety and efficacy of repeated intra-hepatic artery and intravenous infusion of ET140202, a novel anti-AFP/MHC complex T-cell, in advanced hepatocellular carcinoma. 会议论文
作者:  Peng, Min;  Li, Na;  Chang, Chelsea;  Yao, Yi;  Xu, Bin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Efficacy and safety of shorter duration of adjuvant trastuzumab for patients with HER2 positive early breast cancer: A meta-analysis of randomized controlled trials 会议论文
作者:  Li, J.;  Wang, G.;  Wu, Q.;  Chen, C.;  Tu, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis 会议论文
作者:  Peng, M.;  Weng, Y.;  Yao, Y.;  Song, Q.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace